Content about DSN AM

WOONSOCKET, R.I. and WEST ORANGE, N.J. — CVS Caremark’s MinuteClinic and Barnabas Health in New Jersey have signed a clinical collaboration to enhance access to healthcare services in Monmouth and Ocean counties.

WASHINGTON — A division of drug maker Teva Pharmaceutical Industries is partnering with an advocacy group focused on asthma in the launch of a new educational website about the condition.

The Asthma and Allergy Foundation of America and Teva Respiratory announced the launch of Get Smart About Asthma, which aims to increase understanding of how inflammation in the airways contributes to the disease's persistence and severity, as well as providing other educational materials.

ST. LOUIS — Perrigo and a subsidiary of K-V Pharmaceutical Co. have launched a new drug for yeast infections in women, the two companies said.

Perrigo and Ther-Rx Corp. announced the availability of Gynazole-1 (butoconazole nitrate vaginal cream) in the 2% strength for treating yeast infections in nonpregnant women.

Ther-Rx has a partnership with Perrigo to manufacture the drug.

MISSISSAUGA, Ontario — Canadian pharmacy retailer Rexall has unveiled its new flagship private brand, Be.better, a line of more than 100 products available exclusively at the more than 300 corporate Rexall and Rexall Pharma Plus stores.

CHICAGO — One-in-5 consumers between the ages of 35 years and 54 years are choosing products due to a loyalty card discount, SymphonyIRI Group reported Wednesday as part of its fourth quarter 2012 MarketPulse survey. And almost one-third are forsaking their preferred brands due to a sale price. The survey found that shopper sentiment dropped to its lowest point since Q3 2011.

OMAHA, Neb. — A new version of ConAgra Foods' Pam cooking spray is designed to be calorie-free and leave less residue, the company said.

The food company said that the new Pam leaves up to 99% less residue and is available in three varieties: original, baking and butter.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for removing excess iron from the blood in patients with a rare genetic disorder, the agency said.

The FDA announced the approval of Novartis' Exjade (deferasirox) for patients ages 10 years and older with chronic iron overload resulting from nontransfution-dependent thalassemia, or NTDT. A companion diagnostic, FerriScan, made by Australia-based Resonance Health, also was approved.

ANKENY, Iowa — Hy-Vee has started building a new store in Iowa, the supermarket chain said.

Hy-Vee announced that the 92,000-sq.-ft. store would be the second in the planned community of Ankeny, Iowa. The company plans to open the store in late 2013.

The new store will include a Starbucks coffee outlet, pharmacy with drive-through service, gelato bar, Chinese buffet, sushi bar and other amenities, as well as an on-site convenience store and gas station.

NEW BRUNSWICK, N.J. — Johnson & Johnson expects to return about 75% of its OTC brands to the marketplace over the course of 2013, Alex Gorsky, J&J chairman and CEO told analysts Tuesday. "I’m very pleased with the progress that we’re making in that," he said. "We mentioned to you that the consent decree that we had designed in conjunction with the FDA was approved and reviewed in October, with very few comments. And given the breadth and scale of that agreement, we felt very good about that. We’ve had teams working hard since then.

ALEXANDRIA, Va. — A lobbying organization for independent pharmacies has launched an ad campaign in The Hill, the Washington-based daily newspaper covering Congress.

The National Community Pharmacists Association ad lays out the group's legislative agenda for the 113th Congress and the Obama administration.

SCHLIEREN, Switzerland — Cytos Biotechnology will regain rights to an experimental vaccine against nicotine addiction that it had licensed to Novartis, Cytos said Wednesday.

The company said that Novartis would discontinue the project, known as NIC002. Cytos granted Novartis a license for NIC002 in 2007, but phase-2 trial results in October 2009 indicated that the vaccine spurred the development of nicotine-specific antibodies in patients, but did not increase smoking cessation.

PHILADELPHIA — Five pharmacies dominated prescription drug dispensing revenues in the United States last year, according to a new study.

The proprietary study, by the Drug Channels Institute, found that pharmacy retailers CVS Caremark, Walgreens, Rite Aid, Walmart and pharmacy benefit manager Express Scripts accounted for 63% of all prescription drug revenues in the $276.5 billion U.S. pharmacy industry in 2012.